摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

herqueinone | 22212-27-7

中文名称
——
中文别名
——
英文名称
herqueinone
英文别名
4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl-8,9-dihydro-7aH-phenaleno[1,2-b]furan-3,7-dione;(+/-)-isoherqueinone;(+/-)-Isoherqueinon;Isoherqueinon;Herqueinon;Herqueinone o Isoherqueinone;4,6,7a-trihydroxy-5-methoxy-1,8,8,9-tetramethyl-9H-phenaleno[1,2-b]furan-3,7-dione
herqueinone化学式
CAS
22212-27-7
化学式
C20H20O7
mdl
——
分子量
372.375
InChiKey
PKJJEYCUTMFGJW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    27
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    113
  • 氢给体数:
    3
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    溶剂黄146herqueinone 生成 alkaline earth salt of/the/ methylsulfuric acid
    参考文献:
    名称:
    Atrovenetin和一些相关的Herqueinone衍生物的组成
    摘要:
    已证明脱氧, herqueinone和atrovenetin是相同的。根据光谱证据,这些化合物和相关物质已被表征为取代的9-羟基哌嗪酮。通过氧化降解为适当的萘酐以及进一步氧化为硝基古库斯酸,可以证实该结论。已经确定了重要的氧化产物C 15 H 14 O 9 N 2的组成,该产物通过硝酸作用于Atrovenetin而获得。基于该证据和其他证据,阐明了Atrovenetin的组成及其某些转化产物。
    DOI:
    10.1016/0040-4020(59)80035-1
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 、 alkaline earth salt of/the/ methylsulfuric acid 在 potassium carbonate丙酮 作用下, 生成 herqueinone
    参考文献:
    名称:
    微生物生物化学研究。96.黑青霉Bainier和Sartory的色素。
    摘要:
    DOI:
    10.1042/bj0610456
点击查看最新优质反应信息

文献信息

  • Brooks; Morrison, Journal of the Chemical Society. Perkin transactions I, vol. I, p. 1972 421, 430
    作者:Brooks、Morrison
    DOI:——
    日期:——
  • Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications
    申请人:Keller T. Bradley
    公开号:US20070203246A1
    公开(公告)日:2007-08-30
    The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an HMG CoA reductase inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor.
  • [EN] COMBINATIONS COMPRISING (S)-AMLODIPINE AND A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION<br/>[FR] COMBINAISONS COMPRENANT (S)-AMLODIPINE ET UN INHIBITEUR DE LA PROTEINE DE TRANSFERT DE L'ESTER DE CHOLESTERYLE, ET METHODES PERMETTANT DE REDUIRE L'HYPERTENSION
    申请人:SEPRACOR INC
    公开号:WO2005117869A1
    公开(公告)日:2005-12-15
    One aspect of the present invention relates to pharmaceutical compositions comprising optically pure (S)-amlodipine and a cholesteryl ester transfer protein inhibitor. In certain embodiments, the cholesteryl ester transfer protein is torcetrapib, JTT-705, or SC-795. In a preferred embodiment, the cholesteryl ester transfer protein is torcetrapib. In certain embodiments, said optically pure (S)-amlodipine is optically pure (S)-amlodipine malate, or a polymorph, pseudopolymorph or solvate thereof. Another aspect of the present invention relates to a method of treating a patient suffering from hypertension, hyperlipidemia, or a cardiac disorder, comprising co-administering a therapeutically effective amount of optically pure (S)-amlodipine and a cholesteryl ester transfer protein inhibitor. In certain embodiments, said optically pure (S)-amlodipine is optically pure (S)­amlodipine malate, or a polymorph, pseudopolymorph or solvate thereof.
  • [EN] COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES<br/>[FR] COMPOSITIONS ET PROCÉDÉS ASSOCIÉS À DES OXYDES DISSOUS
    申请人:NATURAL EXTRACTION SYS LLC
    公开号:WO2021042001A1
    公开(公告)日:2021-03-04
    Various aspects of this patent document relate to compositions that comprise an anion that is the conjugate base of a hydrophobic molecule that has a pKa, for example, of at least 7 and no greater than 12. These compositions display improved properties when formulated to interact with an organism because the anions carry negative charges that allows them to both dissolve in water-miscible liquids and maximize their surface area. Interaction with an organism results in at least partial conversion of the anion into the hydrophobic molecule after which the hydrophobic molecule partitions out of a water-miscible liquid and into the organism.
  • Studies in the biochemistry of micro-organisms. 96. The colouring matters of <i>Penicillium herquei</i> Bainier &amp; Sartory
    作者:J. A. Galarraga、K. G. Neill、H. Raistrick
    DOI:10.1042/bj0610456
    日期:1955.11.1
查看更多

同类化合物

黄药子素C 黄独素A 香紫苏内酯 降龙涎香醚 阿霉素(α-β混合物) 银线草内酯醇 辛辣木素 载脂蛋白-土霉素 萘并[2,3-c]呋喃-3(1H)-酮 萘并[2,3-c]呋喃-1,3-二酮,5,8-二甲基-(9CI) 萘并[2,3-c]呋喃-1(3H)-酮,4-(3-呋喃基)-7-羟基- 萘并[2,3-b]呋喃-4,9-二酮,2,3-二氢-2-甲基-2-苯基- 萘并[2,1-b]呋喃-2-甲酰肼 萘并[2,1-b]呋喃-2(1H)-酮 萘并[2,1-b]呋喃-1-乙酸 萘并[1,2-b]呋喃-2-醇,2,3,3a,4,5,5a,6,7,9a,9b-十氢-3,5a,9-三甲基- 萘并[1,2-b]呋喃-2(3H)-酮,3a,4,5,9b-四氢-8-羟基-3,9-二甲基-,(3R,3aR,9bS)-rel- 萘并(2,3-b)呋喃-4,9-二酮 萘[2,1-b]呋喃-2-羧酸乙酯 荧蒽-2,3-二甲酸酐 苯并[g][1]苯并呋喃-8,9-二酮 苯并[g][1]苯并呋喃-3-酮 苯并[g][1]苯并呋喃-2-甲醛 苯并[g][1]苯并呋喃 苯并[f][1]苯并呋喃-3-酮 苯并[e][1]苯并呋喃-8-醇 苯并[e][1]苯并呋喃-1-酮 苯并[e][1]苯并呋喃 苯并[b]萘并[2,3-d]呋喃 苯并[b]萘并[2,1-d]呋喃 苯并[b]萘并[1,2-d]呋喃 苯并[B]萘并[2,3-D]呋喃-2-羟基硼酸 苯基(6,7,8,9-四氢萘并[2,1-b]呋喃-2-基)甲醇 苊并[5,4-b]呋喃-4,5-二酮,7,8-二氢-3,6-二羟基-1,7,7,8-四甲基-,(8S)- 维生素K1相关化合物 红葱酚 白术内酯 I 珀勒内B 珀勒内A 沃拉帕沙杂质 沃拉帕沙 沃拉帕沙 沃拉帕沙 己二酸,聚合2,2-二(羟甲基)-1,3-丙二醇,1,3-异苯并呋喃二酮和2,2-氧代二乙醇,2-丙烯酸酯 岩大戟内酯B 岩大戟内酯A 密叶辛木素 咖啡醇 咖啡豆醇乙酸酯 咖啡豆醇